Keywords: AE; Adverse event; GMT; Geometric mean titer; hSBA; Serum bactericidal assay with human complement; PP; Per-protocol; rSBA; Serum bactericidal assay with rabbit complement;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AEFI; Adverse events following immunization; CCC; Complex chronic condition; CFR; Case fatality ratio; hSBA; Human serum bactericidal assay; ICER; Incremental cost-effectiveness ratio; IMD; Invasive meningococcal disease; IMPACT; Immunization Monitoring P
Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study
Keywords: Asplenia; Neisseria meningitidis; Meningococcal disease; Meningococcal vaccine; Immunogenicity; Safety; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; GMC; geometric mean concent
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study
Keywords: AE; adverse event; ATP; according-to-protocol; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; GMT; geometric mean titre; hSBA; human complement serum bactericidal antibody assay; MenACWY-TT; quadrival
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults
Keywords: ACIP; Advisory Committee on Immunization Practices; EMA; European Medicines Agency; FDA; US Food and Drug Administration; FHbp; factor H binding protein; GMT; geometric mean titer; HPV; human papillomavirus; hSBA; serum bactericidal assay using human comp
Antibody persistence and booster response 68â¯months after vaccination at 2-10â¯years of age with one dose of MenACWY-TT conjugate vaccine
Keywords: AEs; adverse events; ATP; according-to-protocol; CIs; confidence intervals; GI; gastrointestinal; GMTs; geometric mean titers; hSBA; serum bactericidal activity assay using human complement; IMD; invasive meningococcal disease; M; month; MenB; meningococc
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Keywords: 4CMenB vaccination; Reduced doses; Catch-up dose; Infants; Children; AE; adverse event; CI; confidence interval; 4CMenB; multi-component vaccine against MenB; fHbp; factor H binding protein; GMT; geometric mean titers; hSBA; serum bactericidal assay with
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers
Keywords: Neisseria meningitidis; Serogroup B; Vaccine; Meningococcal disease; Bivalent rLP2086; Laboratory worker; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; fHBP; factor H binding protein; GMT; geometric mean t
Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
Keywords: MenB; serogroup B meningococcal; fHbp; factor H binding protein; NadA; Neisseria adhesin A; NHBA; Neisseria heparin binding antigen; PorA; porin A; hSBA; serum bactericidal assay using human complement; GMC; geometric mean concentration; GMT; geometric me
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination
Keywords: NCT01823536; Meningococcal vaccine; Childhood vaccination; Antibody persistence; Booster vaccination; hSBA; serum bactericidal assay using human complement; CRM197; non-toxic mutant of diphtheria toxin; IMD; invasive meningococcal disease; GMT; geometric
Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy
Keywords: 95% CI; 95 percent confidence interval; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; ATP; according-to-protocol; Coad; co-administration treatment group who received MenACWY-TTÂ +Â DTaP at the fourth dose visit (15/18 months of a
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults
Keywords: IMD; invasive meningococcal disease; MenC; serogroup C meningococcal disease; MenB; serogroup B meningococcal disease; MCCV; meningococcal serogroup C conjugate vaccine; MenACWY; serogroups A, C, W, Y meningococcal disease; OMV; outer membrane vesicle; fH
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
Keywords: NCT01272180; Conjugate vaccines; Meningococcal; Immunogenicity; Safety; Adolescent; hSBA; serum bactericidal activity with human complement; fHbp; factor H-binding protein; NadA; Neisseria adhesin A; NHBA; Neisserial Heparin Binding Antigen; OMV; outer me
Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2-18 years in Taiwan: Results of an open label study
Keywords: AE; adverse event; CI; confidence interval; GMT; geometric mean titre; GMR; GMT ratio; hSBA; serum bactericidal activity assay with human complement; MITT; modified intent-to-treat; SAE; serious adverse event; Meningococcal disease; Immunogenicity; Safety
Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study
Keywords: Meningococcal disease; Japanese encephalitis; Rabies; Vaccine; Co-administration; AE; adverse event; CI; confidence interval; GMC; geometric mean concentration; GMT; geometric mean titer; hSBA; serum bactericidal activities with human complement; JE; Japa
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
Keywords: CC; clonal complex; ELISA; enzyme-linked immunosorbent assay; fHBP; factor H binding protein; FN; false negatives; FP; false positives; HPA; Health Protection Agency; hSBA; serum bactericidal antibody assay with human complement; IMD; invasive meningococc
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers
Keywords: MMRV; measles, mumps, rubella, varicella, vaccine; MMR; measles, mumps and rubella virus vaccine; hSBA; serum bactericidal activity assay with human complement; ELISA; enzyme-linked immunosorbent assay; LL; lower limit; CI; confidence interval; GMT; geome
Metal-organic molecular architectures with 2,2â²-bipyridyl-like and carboxylate ligands
Keywords: bpy; 2,2â²-bipyridine; dmbpy; 4,4â²-dimethyl-2,2â²-bipyridine; dmphen; 2,9-dimethyl-1,10-phenanthroline; Hglyo; glycolic acid; Hobpy; 6-hydroxy-2,2â²-bipyridine; Hophen; 2-hydroxy-1,10-phenanthroline; 3-Hpya; trans-3-(3-pyridyl)acrylic acid; 4-Hpya; 4